Plasma Atrial Natriuretic Peptide Predicts Oxidized Low-Density Lipoprotein Levels in Type 2 Diabetes Mellitus Patients Independent of Circulating Adipokine and Cytokine
Authors:
- Ahmed BakillahAhmed Bakillah
- Maram Al SubaieeMSMaram Al Subaiee
- Ayman Farouk SolimanASAyman Farouk Soliman
- Khamis Khamees ObeidKOKhamis Khamees Obeid
- Shahinaz Faisal BashirShahinaz Faisal Bashir
- Arwa Al HussainiAHArwa Al Hussaini
- Mohammad Al ArabMAMohammad Al Arab
- Abeer Al OtaibiAOAbeer Al Otaibi
- Sindiyan Al Shaikh MubarakSMSindiyan Al Shaikh Mubarak
- Ali Ahmed Al QarniAQAli Ahmed Al Qarni
Open Access
- 21 February 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 1859
Abstract
Atrial natriuretic peptide (ANP) and oxidized low-density lipoprotein (ox-LDL) play essential roles in the development and progression of vascular complications associated with type 2 diabetes mellitus (T2DM), and both are independently linked to cardiovascular diseases (CVD). However, the relationship between ANP and ox-LDL in patients with T2DM remains unclear as previous studies have primarily focused on circulating levels in various diseases. This study investigated the relationship between ANP and ox-LDL levels in obese individuals with T2DM. The cohort included 57 patients with T2DM (mean age 61.14 ± 9.99 years; HbA1c 8.66 ± 1.60%; BMI 35.15 ± 6.65 kg/m2). Notably, 95% of the patients had hypertension, 82% had dyslipidemia, 59% had an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2, 14% had coronary artery disease (CAD), and 5% had a history of stroke. Plasma concentrations of ANP and ox-LDL were measured using ELISA. Adipokines and cytokines levels were measured using the multiplex® MAP Human Adipokine Magnetic Beads Spearman’s correlation analysis which revealed a negative correlation between ANP and ox-LDL (r = −0.446, p = 0.001) as well as with the ox-LDL/apoB ratio (r = −0.423, p = 0.001) and ox-LDL/LDLc ratio (r = −0.307, p = 0.038). Multivariable regression analysis indicated that ANP was independently associated with ox-LDL (β = −115.736, p = 0.005). Stepwise linear regression further identified TNFα, leptin, and adiponectin as the strongest predictors influencing the relationship between ANP and ox-LDL levels (β = −64.664, p = 0.0311, and r2 = 0.546 for the model). However, these factors did not significantly mediate this association. This study emphasizes the need for further exploration of the complex interaction between ANP and ox-LDL in larger patient populations. This could provide valuable insights into potential therapeutic approaches for managing vascular complications in obese individuals with T2DM.Keywords
Funding Information
- King Abdullah International Medical Research Center (KAIMRC) (RA-18/021A)
This publication has 72 references indexed in Scilit:
- Cardiac natriuretic peptides2024
- Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without Type 2 DiabetesObesity, 2021
- Corin is highly expressed in atherosclerosis modelsBiochemical and Biophysical Research Communications, 2018
- Oxidized LDL but not total LDL is associated with HbA1c in individuals without diabetesClinica Chimica Acta, 2017
- Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptorsCytokine, 2012
- Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPKBiochemical and Biophysical Research Communications, 2011
- Association between oxidized LDL, obesity and type 2 diabetes in a population‐based cohort, the Health, Aging and Body Composition StudyDiabetes/Metabolism Research and Reviews, 2009
- Natriuretic Peptides: Their Structures, Receptors, Physiologic Functions and Therapeutic Applications2009
- Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic SyndromeJAMA, 2008
- Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissueDiabetologia, 2007